drugset / Trial / NCT05141110

Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects

NCT05141110 ↗

Phase 1 Completed 50 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the pharmacokinetics and safety of NVP-1705 and NVP-1705-R.

Timeline

Start
2021-12-29
Primary completion
2022-04-27
Completion
2022-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-1705 Unknown — Oral
Comparator NVP-1705-R Unknown — Oral

Indications

No indication recorded.